Over the 90-day window ending February 07, 2026, Ligand Pharmaceuticals's three dominant insider ownership positions are held by Director John L Higgins (417.69K shares), Other Matthew W Foehr (162.19K shares), Chief Executive Officer Todd C Davis (161.34K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| John L Higgins | 417,695 | 30 Dec, 2022 | |
| Matthew W Foehr | 162,187 | 03 Nov, 2022 | |
| Todd C Davis | Chief Executive Officer | 161,337 | 08 Dec, 2025 |
| Jason Aryeh | 71,323 | 08 Dec, 2025 | |
| Matthew E Korenberg | President & Coo | 50,777 | 24 Sep, 2024 |
| John W Kozarich | 43,187 | 04 Feb, 2026 | |
| Stephen L Sabba | 33,793 | 10 Jun, 2025 | |
| Andrew Reardon | Clo & Secretary | 30,811 | 12 Aug, 2025 |
| John L Lamattina | 30,724 | 12 Nov, 2025 | |
| Sunil Patel | 28,820 | 03 Nov, 2022 | |
| Octavio Espinoza | Chief Financial Officer | 28,575 | 06 Jan, 2026 |
| Charles S Berkman | 23,825 | 03 Nov, 2022 | |
| Nancy Ryan Gray | 8,094 | 12 Nov, 2025 | |
| Jason Haas | 6,606 | 10 Jun, 2025 | |
| Martine Zimmermann | 4,443 | 24 Sep, 2025 | |
| Sarah Boyce | 2,892 | 03 Nov, 2022 | |
| Jennifer R. Cochran | 1,161 | 03 Nov, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | John W Kozarich | Common Stock | D | 23 | $197.20 | 43,187 | D | S |
| 02 Feb, 2026 | John W Kozarich | Common Stock | D | 39 | $191.00 | 43,615 | D | S |
| 02 Feb, 2026 | John W Kozarich | Common Stock | D | 1 | $192.18 | 43,614 | D | S |
| 02 Feb, 2026 | John W Kozarich | Common Stock | D | 381 | $196.36 | 43,210 | D | S |
| 02 Feb, 2026 | John W Kozarich | Common Stock | D | 23 | $195.60 | 43,591 | D | S |
| 02 Jan, 2026 | John W Kozarich | Common Stock | D | 91 | $187.95 | 44,009 | D | S |
| 02 Jan, 2026 | John W Kozarich | Common Stock | D | 21 | $186.59 | 44,100 | D | S |
| 02 Jan, 2026 | John W Kozarich | Common Stock | D | 46 | $192.40 | 43,654 | D | S |
| 02 Jan, 2026 | John W Kozarich | Common Stock | D | 207 | $190.27 | 43,700 | D | S |
| 02 Jan, 2026 | John W Kozarich | Common Stock | D | 102 | $188.96 | 43,907 | D | S |
| 31 Dec, 2025 | Octavio Espinoza | Common Stock | A | 8 | $95.68 | 28,575 | D | J |
| 16 Dec, 2025 | Octavio Espinoza | - | - | 27,734 | D | |||
| 16 Dec, 2025 | Octavio Espinoza | - | - | 28,567 | D | |||
| 16 Dec, 2025 | Octavio Espinoza | Common Stock | A | 652 | $92.65 | 28,386 | D | M |
| 16 Dec, 2025 | Octavio Espinoza | - | - | 28,386 | D | |||
| 16 Dec, 2025 | Octavio Espinoza | Common Stock | A | 181 | $103.42 | 28,567 | D | M |
| 16 Dec, 2025 | Octavio Espinoza | Common Stock | A | 285 | $63.62 | 27,734 | D | M |
| 16 Dec, 2025 | Octavio Espinoza | Common Stock | A | 69 | $57.22 | 27,449 | D | M |
| 16 Dec, 2025 | Octavio Espinoza | - | - | 27,449 | D | |||
| 16 Dec, 2025 | Octavio Espinoza | Common Stock | A | 1,194 | $52.84 | 27,380 | D | M |